Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical: Archive
5 Growth Stocks to Buy for Steady Returns in May
by Nalak Das
We have narrowed our search to five growth stocks that have solid upside left for 2024. These stocks are NFLX, WING, PATH, SKX and MEDP.
NFLXPositive Net Change SKXPositive Net Change PATHNegative Net Change WINGNegative Net Change MEDPNegative Net Change
business-services consumer-discretionary medical restaurants
Best Momentum Stock to Buy for May 8th
by Zacks Equity Research
HIMS, CHRW and WRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 8, 2024.
CHRWPositive Net Change WRKPositive Net Change HIMSNegative Net Change
medical transportation
3 Stocks Backed by High Efficiency to Strengthen Your Portfolio
by Santanu Roy
Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.
GRMNNo Net Change OPCHNegative Net Change LFWDPositive Net Change
communications medical medical-devices
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
by Zacks Equity Research
Dr. Reddy's (RDY) posts better-than-expected fiscal fourth-quarter results on growth in global generics revenues in North America as well as Emerging Markets.
RDYPositive Net Change LGNDPositive Net Change ANIPNegative Net Change BBIONegative Net Change
earnings medical pharmaceuticals
Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View
by Zacks Equity Research
Veracyte's (VCYT) first-quarter 2024 performance reflects the strength of its testing business.
RMDNegative Net Change VCYTNegative Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall
by Zacks Equity Research
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
RMDNegative Net Change GMEDPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Pick These 5 Lucrative GARP Stocks Using PEG Ratio
by Urmimala Biswas
The GARP approach is for investors who are on the lookout for a mixed investment strategy. MGM, THC, ALL, RCL and EAT are some of the stocks that qualify our screening of GARP stocks.
RCLPositive Net Change EATPositive Net Change ALLPositive Net Change THCNegative Net Change MGMNegative Net Change
consumer-discretionary earnings finance insurance medical retail
New Strong Buy Stocks for May 8th
by Zacks Equity Research
BRFS, GPS, GTN, HIMS and SIGA have been added to the Zacks Rank #1 (Strong Buy) List on May 8, 2024.
GPSPositive Net Change BRFSPositive Net Change SIGANegative Net Change GTNPositive Net Change HIMSNegative Net Change
consumer-discretionary consumer-staples medical retail
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
by Zacks Equity Research
DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.
DVANegative Net Change ADUSPositive Net Change EHCNegative Net Change PNTGPositive Net Change OPCHNegative Net Change
medical
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
by Zacks Equity Research
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
ALCNegative Net Change PACBNegative Net Change IGMSNegative Net Change ERASNegative Net Change
earnings medical medical-devices
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
by Zacks Equity Research
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change IARTNegative Net Change
earnings medical medical-devices
Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect
by Zacks Equity Research
Investors' focus will likely be on revenues generated by Guardant Health (GH) from its precision oncology testing business.
ANIPNegative Net Change ANABPositive Net Change ARGXNegative Net Change GHNegative Net Change
biotechs medical oncology-screening
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
by Zacks Equity Research
Rocket Pharmaceuticals' (RCKT) first-quarter earnings beat estimates. Devoid of marketed drugs, the company did not report any revenues during the quarter.
UTHRNegative Net Change LGNDPositive Net Change ANIPNegative Net Change RCKTNegative Net Change
biotechs earnings gene-editing gene-therapy medical
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
by Zacks Equity Research
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
BSXNegative Net Change ECLPositive Net Change DGXNegative Net Change ALGNNegative Net Change
medical
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
by Zacks Equity Research
Perrigo (PRGO) reports mixed first-quarter 2024 results. Management reiterates its financial outlook for 2024.
UTHRNegative Net Change PRGOPositive Net Change LGNDPositive Net Change ANIPNegative Net Change
earnings medical
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
LGNDPositive Net Change ANIPNegative Net Change APLSNegative Net Change ANVSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
BSXNegative Net Change ECLPositive Net Change ALGNNegative Net Change SWAVPositive Net Change
earnings medical medical-devices
Henry Schein (HSIC) Tops Q1 Earnings, Lowers '24 Sales View
by Zacks Equity Research
Henry Schein's (HSIC) first-quarter performance reflects a strong recovery from last year's cyber incident.
RMDNegative Net Change HSICPositive Net Change MEDPNegative Net Change EHCNegative Net Change
earnings medical medical-devices
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
by Nalak Das
We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.
DVANegative Net Change ADUSPositive Net Change EHCNegative Net Change PNTGPositive Net Change OPCHNegative Net Change
medical
GE HealthCare (GEHC) Unveils Head-Only MR Scanner SIGNA MAGNUS
by Zacks Equity Research
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
BSXNegative Net Change ECLPositive Net Change ALGNNegative Net Change GEHCNegative Net Change
medical medical-devices
Best Momentum Stock to Buy for May 7th
by Zacks Equity Research
LDOS, FCBC and UTHR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 7, 2024.
UTHRNegative Net Change FCBCPositive Net Change LDOSPositive Net Change
aerospace finance medical
Best Value Stocks to Buy for May 7th
by Zacks Equity Research
UTHR and NWPX made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 7, 2024.
UTHRNegative Net Change NWPXNegative Net Change
medical
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
by Zacks Equity Research
BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
BMRNNegative Net Change LGNDPositive Net Change BPMCPositive Net Change IMVTPositive Net Change KYMRPositive Net Change
medical
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
by Shaun Pruitt
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
LGNDPositive Net Change PENNegative Net Change OSCRPositive Net Change
earnings investing medical medical-devices
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
PetIQ's (PETQ) first-quarter results are likely to reflect growth in the Product and Services segments of the business.
ALCNegative Net Change BPMCPositive Net Change ADVMNegative Net Change PETQPositive Net Change
medical medical-devices